Future for folates in cardiovascular disease
- 1 August 1999
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 29 (8) , 657-658
- https://doi.org/10.1046/j.1365-2362.1999.00526.x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Oral folate enhances endothelial function in hyperhomocysteinaemic subjectsEuropean Journal of Clinical Investigation, 1999
- Demonstration of Rapid Onset Vascular Endothelial Dysfunction After HyperhomocysteinemiaCirculation, 1999
- Nitric oxide and hypercholesterolemia: a matter of oxidation and reduction?Atherosclerosis, 1998
- Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione PeroxidaseJournal of Biological Chemistry, 1997
- Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action ProjectPublished by American Medical Association (AMA) ,1997
- Mortality by cause for eight regions of the world: Global Burden of Disease StudyPublished by Elsevier ,1997
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakesPublished by American Medical Association (AMA) ,1995
- Serum Folate and Risk for Ischemic StrokeStroke, 1995
- Can Lowering Homocysteine Levels Reduce Cardiovascular Risk?New England Journal of Medicine, 1995
- Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.Circulation, 1990